Clinical Trial Update: Skin Prick Tests With AllerT in Subjects Allergic to Birch Pollen [Phase 1]

View source ↗

Summary

Phase 1 skin prick test evaluating AllerT in birch pollen-allergic individuals with allergic rhinitis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• AllerT

Snippet

Sponsor: Anergis | Conditions: Allergic Rhinitis | Phase 1 | Status: COMPLETED